Assessment of CCR5i/maraviroc immunotherapy in combination with PD1 and MR-guided radiotherapy for treatment of pancreatic cancer
Lanfredini S., Hughes S., Thapa A., Bangs F., Morton J., Allen D., Kersemans V., Kinchesh P., Smart S., Elliot A., Thompson J., Hill M., Mukherjee S., O'Neill E.